Physician profile
Gary Starkman
NPI 1487686119
$1,858.36
in general payments reported to CMS, 2019-2025
17 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $186 · 2021: $154 · 2022: $311 · 2023: $184 · 2024: $152 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738 · Education: $81.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.84 |
| Education | $81.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $836.73 | 2021-2025 | Botox |
| Allergan, INC. | $241.32 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $154.34 | 2019-2023 | Rytary |
| Teva Pharmaceuticals USA, INC. | $125.71 | 2021-2025 | |
| Amgen INC. | $118.55 | 2020-2024 | Uplizna |
| Supernus Pharmaceuticals, INC. | $76.87 | 2019-2020 | |
| Bausch Health US, LLC | $46.08 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.02 | 2019 | |
| Depuy Synthes Sales INC. | $42.77 | 2019-2022 | |
| Biogen, INC. | $41.85 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.82 | 2019 | |
| Ucb, INC. | $20.85 | 2019 | |
| Vertical Pharmaceuticals, LLC | $17.57 | 2020 | |
| Celgene Corporation | $17.26 | 2022 | |
| Almatica Pharma LLC | $16.60 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $15.00 | 2022 | |
| Boston Scientific Corporation | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Starkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.